Alnylam Germany GmbH, based in Munich, is a wholly owned subsidiary of Alnylam UK Ltd. and part of the Alnylam group with ultimate parent Alnylam Pharmaceuticals, Inc. The company is primarily engaged in the distribution and marketing of Alnylam products in the German market and realizes its revenues predominantly in euros from pharmacies and hospitals. In 2024 the company marketed four approved products (AMVUTTRA, ONPATTRO, GIVLAARI and OXLUMO) and achieved product sales of 84,461 TEUR, an increase of 27.9% versus 2023. Research and development activities are performed within the group by other Alnylam entities; Alnylam Germany itself recorded no R&D expenditures in 2024.
Forschung, Entwicklung und Vertrieb von pharmazeutischen Produkten im humanen Bereich. Ausgenommen sind erlaubnispflichtige Tätigkeiten jeder Art, sofern nicht eine Erlaubnis vorliegt.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) München Local Court, HRB 224597 (as of 29 September 2026)
Source: German Commercial Register (Handelsregister) München Local Court, HRB 224597 (as of 29 September 2026)
Source: German Commercial Register (Handelsregister) München Local Court, HRB 224597 (as of 29 September 2026)
Sign in to download data
Source: German Commercial Register (Handelsregister) München Local Court, HRB 224597 (as of 29 September 2026)
Burgwedel Biotech GmbH
Schwabenheim · Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen Erzeugnissen
Immunic AG
Gräfelfing · Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen Erzeugnissen
Solupharm Pharmazeutische Erzeugnisse GmbH
Melsungen · Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen Erzeugnissen
